Pnc Financial Services Group, Inc. Arcellx, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 265 shares of ACLX stock, worth $17,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265
Previous 291
8.93%
Holding current value
$17,262
Previous $22,000
22.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$293 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$260 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$244 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$229 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$198 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.85B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...